Jane Street Group, LLC Crispr Therapeutics Ag Put Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$53.19 - $79.24 $5.66 Million - $8.43 Million	-106,400 Reduced 27.44%	281,400 $17.7 Million
Q4 2021 Feb 15, 2022	BUY	$70.09 - $111.29 $525,675 - $834,675	7,500 Added 1.97%	387,800 $29.4 Million
Q3 2021 Nov 16, 2021	SELL	$110.2 - $156.64 $13.4 Million - $19 Million	-121,300 Reduced 24.18%	380,300 $42.6 Million
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $1.88 Million - $3.01 Million	18,600 Added 3.85%	501,600 $81.2 Million
Q1 2021 May 18, 2021	BUY	$110.72 - $210.04 $21 Million - $39.9 Million	189,900 Added 64.79%	483,000 $58.9 Million
Q4 2020 Feb 17, 2021	BUY	$79.67 - $173.23 $11.8 Million - $25.6 Million	147,800 Added 101.72%	293,100 $44.9 Million
Q3 2020 Nov 17, 2020	BUY	$78.5 - $100.64 $2.44 Million - $3.13 Million	31,100 Added 27.23%	145,300 $12.2 Million
Q2 2020 Aug 17, 2020	BUY	$38.5 - $76.05 $3.92 Million - $7.73 Million	101,700 Added 813.6%	114,200 $8.39 Million
Q1 2020 May 15, 2020	BUY	$33.68 - $62.53 $195,344 - $362,674	5,800 Added 86.57%	12,500 $530,000
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $245,756 - $489,970	6,700 New	6,700 $408,000

503

57M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.28B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.